Hyundai Recalling Nearly 500,000 Sonatas Due to Potential Engine Failures
Hyundai is recalling nearly 500,000 Sonata sedans because a manufacturing problem could cause their engines to fail.
Hyundai has notified the National Highway Traffic Safety Administration that engines produced at its powertrain plant in Alabama may not have been machined properly. As a result, metal debris can block the flow of oil to the connecting...
Analysis: Why VW’s emissions fraud is such an outrage
Premeditation.
That's the difference between Volkswagen's faked diesel emission tests and earlier auto scandals. It's what makes this worse than GM's ignition switches, Toyota's runaway cars or Ford-Firestone's exploding tires.
Volkswagen set out to cheat emissions tests and sell cars that would damage human health and the environment. The other automakers seemed legitimately baffled and eager...
A Car Scandal Shoves Berlin Off High Ground
BERLIN — As Germany has emerged as the dominant actor in Europe, it has lectured Greece and other debtor nations on the virtues of thrift and lately wagged its finger at countries that balk at receiving a share of refugees from the killing fields of Syria. Its right to lead, based on a narrative...
FDA issues Class I recall of Syncardia Freedom driver
The FDA has issued a Class I recall of a select number of SynCardia Systems Total Artificial Heart Freedom driver.
A Class I recall, the most serious type of recall, indicates “there is a reasonable probability that use of these products will cause serious adverse health consequences or death.”
The mechanical heart replacement is implanted to...
Volkswagen emission scandal widens: 11 million cars affected
Volkswagen's emissions scandal ballooned Tuesday as the company admitted that software designed to fool regulators affects 11 million vehicles worldwide and could cost more than $7 billion to address, threatening to undermine its new position as the world's largest automaker.
The automaker's deception immediately qualifies as one of the most expensive automotive scandals in recent memory and could jeopardize CEO Martin...
Many Messages in the G.M. Settlement
One of the biggest product defects in recent American manufacturing history, linked to at least 124 deaths and numerous injuries, was traceable to a mundane automobile part, the ignition switch. For General Motors, the debacle over how it handled that defect scarred the organization as it had to admit to repeated failures in simply...
After Battling Safety Agency, Recaro Changes Course on Car Seat Recall
The recall seemed to be straightforward enough: Recaro Child Safety needed to fix some of its car seats so that they would not break free during a crash.
But the path to that announcement, made last week, was anything but.
Read more.
CDC: Cyclospora Outbreak Linked to Mexican Cilantro Sickened 546 People
The U.S. Centers of Disease Control and Prevention (CDC) has announced that the recent Cyclospora outbreak sickened 546 people from 31 states from May to August. The numbers of reported cases in the U.S. have returned to baseline levels, the agency noted.
CDC stated that epidemiologic and traceback investigations conducted in Texas, Wisconsin, and Georgia...
Drug Goes From $13.50 a Tablet to $750, Overnight
Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.
The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to...
New prescription drugs can help patients, but their high prices elicit ire
They sounded like three deadly strikes.
The patient had a dangerously high level of LDL cholesterol, a high risk for heart disease and an intolerance for the most common cholesterol-fighting medication. Dr. William Averill, a Torrance cardiologist, thought he had a solution: Praluent, a cholesterol-lowering drug from pharmaceutical companies Regeneron and Sanofi that had just...
